These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28666971)

  • 61. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.
    Szodoray P; Szabó Z; Kapitány A; Gyetvai A; Lakos G; Szántó S; Szücs G; Szekanecz Z
    Autoimmun Rev; 2010 Jan; 9(3):140-3. PubMed ID: 19427413
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Pathologic condition of osteoporosis in rheumatoid arthritis].
    Suwa A; Saito E; Wakabayashi T; Suzuki Y
    Clin Calcium; 2007 Aug; 17(8):1262-6. PubMed ID: 17660625
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides.
    Scinocca M; Bell DA; Racapé M; Joseph R; Shaw G; McCormick JK; Gladman DD; Pope J; Barra L; Cairns E
    J Rheumatol; 2014 Feb; 41(2):270-9. PubMed ID: 24429169
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies.
    Kleyer A; Finzel S; Rech J; Manger B; Krieter M; Faustini F; Araujo E; Hueber AJ; Harre U; Engelke K; Schett G
    Ann Rheum Dis; 2014 May; 73(5):854-60. PubMed ID: 23520034
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association between body mass index and anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis: results from a population-based case-control study.
    Wesley A; Bengtsson C; Elkan AC; Klareskog L; Alfredsson L; Wedrén S;
    Arthritis Care Res (Hoboken); 2013 Jan; 65(1):107-12. PubMed ID: 22674870
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea.
    Choi IA; Kim JH; Kim YM; Lee JY; Kim KH; Lee EY; Lee EB; Lee YM; Song YW
    Korean J Intern Med; 2016 Sep; 31(5):977-86. PubMed ID: 27017391
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The term "seropositive" to qualify polyarthritis/rheumatoid arthritis should be banned.
    Goëb V
    Joint Bone Spine; 2018 Jan; 85(1):123. PubMed ID: 28042041
    [No Abstract]   [Full Text] [Related]  

  • 68. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction.
    Boissier MC; Semerano L; Challal S; Saidenberg-Kermanac'h N; Falgarone G
    J Autoimmun; 2012 Sep; 39(3):222-8. PubMed ID: 22704962
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Bone and calcium metabolism in patients with rheumatoid arthritis].
    Furuya T
    Clin Calcium; 2011 Sep; 21(9):1369-75. PubMed ID: 21881200
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss.
    Richelson LS; Wahner HW; Melton LJ; Riggs BL
    N Engl J Med; 1984 Nov; 311(20):1273-5. PubMed ID: 6493283
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
    Weijers L; Baerwald C; Mennini FS; Rodríguez-Heredia JM; Bergman MJ; Choquette D; Herrmann KH; Attinà G; Nappi C; Merino SJ; Patel C; Mtibaa M; Foo J
    Rheumatol Int; 2017 Jul; 37(7):1111-1123. PubMed ID: 28560470
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective.
    Zhao R
    Int J Med Sci; 2012; 9(9):825-32. PubMed ID: 23136547
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structural mechanisms of bone loss in iliac biopsies: comparison between rheumatoid arthritis and postmenopausal osteoporosis.
    Hanyu T; Arai K; Takahashi HE
    Rheumatol Int; 1999; 18(5-6):193-200. PubMed ID: 10399795
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Are Oxidative Stress and Inflammation Mediators of Bone Loss Due to Estrogen Deficiency? A Review of Current Evidence.
    Mohamad NV; Ima-Nirwana S; Chin KY
    Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1478-1487. PubMed ID: 32496996
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Role of Autoantibodies in Bone Metabolism and Bone Loss.
    Hauser B; Harre U
    Calcif Tissue Int; 2018 May; 102(5):522-532. PubMed ID: 29204673
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Postmenopausal osteoporosis: proposed roles of defective coupling and estrogen deficiency.
    Ivey JL; Baylink DJ
    Metab Bone Dis Relat Res; 1981; 3(1):3-7. PubMed ID: 7266364
    [No Abstract]   [Full Text] [Related]  

  • 77. An integrated view of the role of the endocrine system in the genesis of the osteoporosis associated with aging.
    Arnaud CD
    Osteoporos Int; 1993; 3 Suppl 1():37-9. PubMed ID: 8461573
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Link between estrogen deficiency osteoporosis and susceptibility to bone metastases: A way towards precision medicine in cancer patients.
    Salamanna F; Borsari V; Contartese D; Nicoli Aldini N; Fini M
    Breast; 2018 Oct; 41():42-50. PubMed ID: 30007267
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microbiome-based mechanisms hypothesized to initiate obesity-associated rheumatoid arthritis.
    Luo Y; Blackledge WC
    Obes Rev; 2018 Jun; 19(6):786-797. PubMed ID: 29426061
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Common mechanisms and holistic care in atherosclerosis and osteoporosis.
    Szekanecz Z; Raterman HG; Pethő Z; Lems WF
    Arthritis Res Ther; 2019 Jan; 21(1):15. PubMed ID: 30630495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.